Peripheral Interventions Market By Product Type (Angioplasty Balloons, Stents, Peripheral Vascular Access Devices, Embolic Protection Devices), By Application (Coronary Artery Disease, Peripheral Artery Disease, Endovenous Laser Therapy), By End-User (Hospitals & Clinics, Ambulatory Surgical Centers, Research Institutions), and By Region; Global Insights & Forecast (2023 – 2030)

As per Intent Market Research, the Peripheral Interventions Market was valued at USD 10.9 billion in 2024-e and will surpass USD 16.7 billion by 2030; growing at a CAGR of 7.4% during 2025 - 2030.

The peripheral interventions market is witnessing significant growth due to the increasing prevalence of peripheral artery diseases (PAD) and other vascular conditions, alongside technological advancements in medical devices. Peripheral interventions are critical for treating diseases like coronary artery disease (CAD), peripheral artery disease, and varicose veins, offering patients minimally invasive options for effective treatment. As the population ages, the incidence of vascular diseases is rising, driving the demand for advanced intervention devices.

Technological innovations, such as drug-eluting stents and bioresorbable materials, have improved the efficacy and safety of peripheral interventions, contributing to the market's expansion. Furthermore, the growing preference for minimally invasive procedures, along with the increasing awareness of PAD and its associated risks, is encouraging patients to opt for early diagnosis and treatment, fueling market growth. With an ongoing focus on innovation, the market for peripheral interventions is expected to continue expanding, providing healthcare providers with more advanced and patient-friendly treatment options.

Angioplasty Balloons Segment is Largest Owing to Widespread Use in Peripheral Interventions

The angioplasty balloons segment is the largest within the peripheral interventions market due to their widespread use in treating coronary artery disease (CAD) and peripheral artery disease (PAD). Angioplasty balloons are used to dilate narrowed or obstructed arteries, improving blood flow and reducing symptoms associated with these conditions. They are a critical tool in minimally invasive procedures, making them a preferred choice for many healthcare providers.

Angioplasty balloons are available in various sizes and configurations to treat different types of arterial blockages, including drug-coated balloons that help prevent restenosis. Their versatility and effectiveness in treating both coronary and peripheral artery diseases ensure their continued dominance in the market, while ongoing advancements in balloon technology, such as enhanced deliverability and durability, are expected to further boost growth.

Peripheral Vascular Access Devices Segment is Fastest Growing Owing to Rising Demand for Minimally Invasive Procedures

The peripheral vascular access devices segment is the fastest growing in the peripheral interventions market, driven by the increasing demand for minimally invasive procedures and the need for efficient access during interventions. These devices are used to provide stable vascular access for the delivery of medications, fluids, and for performing diagnostic procedures. As the healthcare industry shifts toward minimally invasive treatments, the need for these devices is growing rapidly.

Peripheral vascular access devices are crucial for performing interventional procedures in both emergency and elective settings, providing healthcare professionals with the necessary tools to navigate peripheral vasculature safely. With the rise of outpatient care and ambulatory surgical centers, the demand for such devices is expected to continue growing, driven by improvements in device design and patient safety.

Peripheral Artery Disease Application is Largest Owing to High Prevalence and Severe Impact

The peripheral artery disease (PAD) application segment is the largest in the peripheral interventions market due to the high prevalence of the condition and its severe impact on patient health. PAD is characterized by the narrowing of peripheral arteries, primarily affecting the legs, and can lead to severe complications such as limb ischemia and amputation if left untreated. As the global population ages, the incidence of PAD is on the rise, leading to increased demand for peripheral interventions to manage the condition effectively.

The availability of advanced devices, including angioplasty balloons and stents, has significantly improved outcomes for PAD patients. The market for PAD treatments is expected to continue expanding as awareness increases regarding the importance of early diagnosis and intervention. Additionally, innovations in device technology are likely to enhance the safety and effectiveness of PAD treatments, further driving the market's growth.

Hospitals & Clinics Segment is Largest End-User Owing to High Patient Volume and Advanced Medical Facilities

Hospitals and clinics remain the largest end-user segment in the peripheral interventions market due to their high patient volume and the availability of advanced medical equipment required for peripheral interventions. These institutions are typically the first point of contact for patients with vascular diseases and are equipped with the necessary infrastructure to perform complex interventions such as angioplasty, stenting, and endovenous laser therapy.

Hospitals and clinics also benefit from the constant advancements in medical technology, allowing them to provide minimally invasive treatments that reduce recovery time and improve patient outcomes. The growing preference for outpatient procedures, combined with the high volume of vascular disease cases, ensures that hospitals and clinics will continue to play a central role in the peripheral interventions market.

North America is Largest Region Owing to Advanced Healthcare Systems and High Incidence of Vascular Diseases

North America is the largest region in the peripheral interventions market, primarily driven by the advanced healthcare systems in the United States and Canada, as well as the high incidence of peripheral artery diseases. The presence of well-established healthcare infrastructure, access to state-of-the-art medical devices, and a strong emphasis on early diagnosis and treatment of vascular diseases contribute to North America's market dominance.

Moreover, the region's growing geriatric population, which is more susceptible to vascular conditions, further drives the demand for peripheral interventions. North America is also home to many leading manufacturers of interventional devices, fueling innovation and improving the availability of advanced treatment options for patients. The region's strong healthcare policies and increasing patient awareness about vascular diseases ensure that it will maintain its leading position in the market.

Competitive Landscape

The peripheral interventions market is competitive, with several major players leading the development and commercialization of innovative medical devices. Companies in the market are focusing on product innovation, including advancements in angioplasty balloons, stents, and vascular access devices, to improve the safety and efficacy of peripheral interventions. Key players are also investing in research and development to introduce drug-eluting and bioresorbable devices, which offer enhanced patient outcomes.

The market is also marked by strategic collaborations, mergers, and acquisitions aimed at expanding product portfolios and geographic reach. Leading companies are increasingly looking to expand their presence in emerging markets, where the demand for vascular interventions is growing rapidly. With the continuous evolution of treatment technologies and the ongoing drive for innovation, the competitive landscape in the peripheral interventions market is expected to remain dynamic and highly competitive.

List of Leading Companies:

• Medtronic
• Abbott Laboratories
• Boston Scientific
• Johnson & Johnson
• Terumo Corporation
• Cordis Corporation
• Cook Medical
• Edwards Lifesciences
• Philips Healthcare
• Spectranetics (a part of Thermo Fisher Scientific)
• Biotronik
• C.R. Bard (now part of BD)
• Avinger
• Gore Medical
• Xtent, Inc.

Recent Developments:

• In December 2024, Medtronic launched a next-generation angioplasty balloon designed for enhanced performance in peripheral artery disease treatment.
• In November 2024, Abbott Laboratories received approval for a new peripheral artery stent with improved flexibility and ease of use.
• In October 2024, Boston Scientific introduced a novel embolic protection device for use during peripheral vascular procedures.
• In September 2024, Johnson & Johnson announced the release of a new vascular access device to improve patient outcomes in peripheral interventions.
• In August 2024, Terumo Corporation expanded its product line to include a new endovenous laser therapy system for the treatment of varicose veins.

Report Scope: